Anemocyte will attend Advanced Therapies Week 2026, one of the leading US partnering and content events for the cell & gene therapy (CGT) ecosystem, hosted by Phacilitate. The conference will take place at the San Diego Convention Center in San Diego on February 9 – 12, 2026.
Key themes at the event
Across the week, discussions and meetings will explore topics that shape the future of advanced therapies, including:
- Cell & gene therapy development and translation to the clinic
- Manufacturing strategy, scale-up, and industrialization
- CMC, quality, and regulatory readiness for advanced modalities
- Enabling technologies and platforms supporting robust production
- Partnering and collaboration models accelerating development paths
Anemocyte at Advanced Therapies Week
At Advanced Therapies Week 2026, Anemocyte will share its integrated approach to non-viral manufacturing solutions and discuss how we support organizations working on advanced therapeutic programs.
In addition to the themes traditionally central to the conference, we will highlight:
- Off-the-shelf plasmid DNA solutions
- Off-the-shelf mRNA solutions
- AMCap™ enzymatic capping technology, designed to support high-quality mRNA workflows with consistency and scalability in mind
These capabilities reflect our focus on providing practical, manufacturing-oriented solutions that help developers move faster while maintaining the standards required for regulated environments.
Meet us at our booth 762
Anemocyte will be exhibiting with a dedicated booth. We invite you to stop by to meet the team, exchange perspectives on current manufacturing challenges, and explore how our technologies and platforms can support your next steps – from early development to GMP manufacturing.
